Reply to ‘Sudden Cardiac Death Following Use of the Synthetic Cannabinoid MDMB-CHMICA’

Sudden Cardiac Death Following Use of the Synthetic Cannabinoid MDMB-CHMICA

(2015) Andreas Austgulen Westin et al.   JOURNAL OF ANALYTICAL TOXICOLOGY

Acute intoxication by synthetic cannabinoids - Four case reports

(2013) Maren Hermanns-Clausen et al.   Drug Testing and Analysis

Distinct pharmacology and metabolism of K2 synthetic cannabinoids compared to Δ9-THC: Mechanism underlying greater toxicity?

(2013) William E. Fantegrossi et al.   LIFE SCIENCES

Human metabolites of synthetic cannabinoids JWH-018 and JWH-073 bind with high affinity and act as potent agonists at cannabinoid type-2 receptors

(2013) Maheswari Rajasekaran et al.   TOXICOLOGY AND APPLIED PHARMACOLOGY

Acute toxicity due to the confirmed consumption of synthetic cannabinoids: clinical and laboratory findings

(2012) Maren Hermanns-Clausen et al.   ADDICTION

Monohydroxylated metabolites of the K2 synthetic cannabinoid JWH-073 retain intermediate to high cannabinoid 1 receptor (CB1R) affinity and exhibit neutral antagonist to partial agonist activity

(2012) Lisa K. Brents et al.   BIOCHEMICAL PHARMACOLOGY

The effect of the postmortem interval on the redistribution of drugs: a comparison of mortuary admission and autopsy blood specimens

(2012) Dimitri Gerostamoulos et al.   Forensic Science Medicine and Pathology

Phase I Hydroxylated Metabolites of the K2 Synthetic Cannabinoid JWH-018 Retain In Vitro and In Vivo Cannabinoid 1 Receptor Affinity and Activity

(2011) Lisa K. Brents et al.   PLoS One